The Rising Prevalence Of Cardiovascular Disorders Propels Growth In Ventricular Assist Device Market: A Significant Driver Propelling The Ventricular Assist Device Market In 2025

The Ventricular Assist Device Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Ventricular Assist Device Market Size and Projected Growth Rate?
In recent times, the market size of ventricular assist devices has experienced swift growth. It is projected to escalate from $2.12 billion in 2024 to $2.39 billion in 2025, with a compound annual growth rate (CAGR) of 12.6%. The upsurge observed in the historical period can be credited to a surge in heart failure cases and an amplified demand for organ transplant operations.

The market size for ventricular assist devices is set to witness exponential growth in the coming years, expanding to $3.91 billion with a 13.1% compound annual growth rate (CAGR) by 2029. This projected growth in the forecast period is linked to various factors such as the rising demand for destination therapy, an aging demographic, increased healthcare spending, and growing awareness about treatments for heart failure. Emerging trends during the forecast period encompass efforts to prolong the functional lifespan of VADs, the miniaturization of VADs, advancements in pump technologies, heightened emphasis on VAD safety and effectiveness, reducing the side effects associated with VADs, and the introduction of percutaneously inserted ventricular assist devices.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6680

What Are the Major Segments in the Ventricular Assist Device Market?
The ventricular assist device market covered in this report is segmented -

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).
2) By Type: Pulsatile Flow, Continuous Flow
3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices
4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy
5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:
1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs
2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs
3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

What Are The Driving Ventricular Assist Device Market Evolution?
The rise in cases of cardiovascular disorders is fueling the expansion of the ventricular assist device market. Factors such as high blood pressure, smoking, high cholesterol, inactivity, and others lead to cardiovascular disorders, which are a type of heart disease. The upsurge in these disorders can also be associated with noncommunicable diseases like diabetes, chronic respiratory disease, and hypertensive heart attacks. This substantial increment in cardiovascular disorders is anticipated to escalate the need for ventricular assist devices, which serve as an essential support system for critically unwell heart patients. The National Library of Medicine, a US federal agency, stated in October 2022 that it's estimated that by 2035, cardiovascular disease will affect 45.1% of the US population. The total expenditure on cardiovascular diseases is projected to hit $1.1 trillion in 2035. Consequently, the rising instances of cardiovascular disorders should stimulate demand for ventricular assist devices within the projected period.

Which Firms Dominate The Ventricular Assist Device Market Segments?
Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

What Trends Are Expected to Dominate the Ventricular Assist Device Market in the Next 5 Years?
The market is witnessing an increase in the popularity of ventricular assist devices inserted percutaneously. These devices, which are non-pulsatile axial flow pumps placed across the aortic valve, function by pumping blood from the left ventricle. They reduce the burden on the left ventricle and decrease the consumption of myocardial oxygen, which enhances cardiac output and lowers left ventricular end-diastolic pressure. For instance, in August 2022, the US-based medical device firm Abiomed Inc. launched Impella, a percutaneously inserted VAD, aimed for qualified pediatric patients in the USA. Serving as a satisfactory cardiac support, the device compensates for a failed left ventricle in patients. Plus, it can either replace extracorporeal membrane oxygenation (ECMO) or be used alongside it to optimize hemodynamics.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Which Is The Largest Region In The Ventricular Assist Device Market?
North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Ventricular Assist Device Market?
2. What is the CAGR expected in the Ventricular Assist Device Market?
3. What Are the Key Innovations Transforming the Ventricular Assist Device Industry?
4. Which Region Is Leading the Ventricular Assist Device Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.